PI
PLEOPHARMA, INC.
SEC filingPharmaceuticals · Phoenixville, PA
Amount raised$5.5Msold at filing
Total offering$15M$9.5M still open
Investors in the raise11count reported to the SEC
FiledAug 10, 2026first sale Jul 28, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kyle TomlinDirector
Ginger ConstantineExecutive Officer, Director
Sarah HassanDirector
Jay ConstantineExecutive Officer, Director
McInerney TimothyDirector
Poche ThomasExecutive Officer
Daniel CartwrightExecutive Officer
Robert FinizioExecutive Officer, Director
Paul BisaroDirector
Tommy ThompsonDirector
Kyle MowitzDirector
Brij SharmaDirector
Executive officers, directors and promoters as listed on the Form D.